Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
BLX 0.5ELF.TO 0.09RY.TO 3.05PEY.TO 0.26CP.TO -0.12BRK.B -0.57MSFT -5.93META 6.73
Valeant Pharmaceuticals (VRX.TO)
The ultimate 360° Tracker Your financial life in one place, automatically

Valeant Pharmaceuticals (VRX.TO)

0.00
-0.00 (0.00%)
39 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
BUY ON WEAKNESS

Valeant Pharmaceuticals(VRX.TO)

Sep 10, 2003
Will be volatile. Buy 10% lower. Treat as a trading stock.
Photo of Richard StoneRichard StoneUnlock Rating
$55.27

Stock price when the opinion was issued

Healthcare
BUY ON WEAKNESS

Valeant Pharmaceuticals(VRX.TO)

Sep 03, 2003
More volatile than average health care stocks. Potential accounting issues. Not cheap. Earnings continue to grow. Buy around $50 with a target of high $50’s or $60. Use a tight stop/loss. A trading stock.
Photo of Peter Arender, CFAPeter Arender, CFAUnlock Rating
$53.66

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Aug 20, 2003
Has had a great run.Very volatile.Would look at it in the mid-$40's range.
Photo of Mark Jackson, CFAMark Jackson, CFA
No
Unlock Rating
$55.80

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Aug 18, 2003
They never quite come up to expectations.Would consider buying in the low $40.Treat as a trading stock.
Photo of Bruce Campbell (1)Bruce Campbell (1)
No
Unlock Rating
$57.74

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Aug 15, 2003
A volatile stock.Chances are greater that it will drop rather than move up.
Photo of Michael SmedleyMichael Smedley
Owned
Unlock Rating
$57.58

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Aug 11, 2003
Volatile.Didn't meet all their numbers.
Photo of Bruce Campbell (1)Bruce Campbell (1)
No
Unlock Rating
$54.71

Stock price when the opinion was issued

Healthcare
BUY ON WEAKNESS

Valeant Pharmaceuticals(VRX.TO)

Aug 08, 2003
Volatile stock.Hold for the long term.Treat as a trading stock in the short term.
Photo of Michael SmedleyMichael Smedley
Owned
Unlock Rating
$55.25

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Aug 07, 2003
Has dropped to a more comfortable level.Likes their pipeline.The growth should support the upward movement in the stock.
Photo of John ZechnerJohn ZechnerUnlock Rating
$53.25

Stock price when the opinion was issued

Healthcare
WEAK BUY

Valeant Pharmaceuticals(VRX.TO)

Jul 23, 2003
Volatile. A lot of news comes out and stock reacts to it all. Very hard to call. Strong management.
Photo of David BaskinDavid BaskinUnlock Rating
$58.85

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jul 22, 2003
Drug sector has started to back off although generic drugs are generally doing quite well. Prefers other areas.
Photo of David BurrowsDavid Burrows
No
Unlock Rating
$59.20

Stock price when the opinion was issued

Healthcare
BUY ON WEAKNESS

Valeant Pharmaceuticals(VRX.TO)

Jul 22, 2003
Sold out at $65 a few weeks ago but bought a bit back at $55. Really a valuation play. Buy in the mid $50's. Speculative.
Photo of Peter Arender, CFAPeter Arender, CFA
Owned
Unlock Rating
$59.20

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jul 21, 2003
A risk to the downside at about 10% below current price.
Photo of Larry Berman CFA, CMT, CTALarry Berman CFA, CMT, CTA
No
Unlock Rating
$55.10

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jul 17, 2003
Very volatile. The drivers for this company are some big drugs that are not growing very much. Prefers Teva.
Photo of Brad WillockBrad WillockUnlock Rating
$58.03

Stock price when the opinion was issued

Healthcare
PAST TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Jul 15, 2003
(Was a top pick on Mar 17/03. Up 1.5%.) Became too volatile, so sold out.
Photo of David BurrowsDavid Burrows
No
Unlock Rating
$59.11

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jul 14, 2003
Bought at $38 and sold for a gain. Too high now.
Photo of Brian Acker, CABrian Acker, CA
No
Unlock Rating
$60.94

Stock price when the opinion was issued

Healthcare
Showing 526 to 540 of 714 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

AVGO -17.23$376.71
CCO.TO 1.26$151.04
TOU.TO -0.47$60.79
BTE.TO -0.22$5.91
ADM -1.25$78.02

Today's Top Picks

BLX 0.5$59.17
ELF.TO 0.09$16.98
RY.TO 3.05$281.51
PEY.TO 0.26$24.91
CP.TO -0.12$124.8

Popular Articles

Latest Sell Signals

OTEX.TO 0.14$30.96
BSX 0.16$46.92
GIL.TO -16.24$70.39
SHOP.TO 1.22$158.49
WCN.TO 3.21$219.59

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Keith Richards

Keith Richards

ValueTrend Wealth Management

Joe Terranova

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica